Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

FDA unveils plan to lower prices, boost competition among drug-makers

The FDA unveiled a new plan to enable market competition for biologics and biosimilars Wednesday, July 18, as part of a larger shift to lower drug prices across the healthcare system.

Thumbnail

Humana hits highest share price ever

With a stake in two post-acute care companies under its belt, health insurer Humana saw its share price hit a new record high last week.

Amazon eyeing investment in Indian pharmacy chain

Retail giant Amazon is in early talk to invest in Medplus, India’s second-largest pharmacy chain, according to FactorDaily.

Thumbnail

HHS diverts $40M to immigration crisis under Trump policy

President Donald Trump’s policy of “zero tolerance” on illegal immigration has led HHS to redirect millions in funding to house migrant children separated from their parents at the border.

Thumbnail

HHS proposals for 340B drug pricing program prompt industry objections

Proposed changes to the 340B drug pricing program, in addition to other cuts in payments, are being called out by industry associations and providers.

Thumbnail

'Breakthrough' drug designations result in less certainty

Speeding up the regulatory process has led to uncertainty about the effectiveness of some new drugs.

Hospital utilization slows as healthcare moves to cheaper care settings

Hospital utilization is slowing down in its growth, according to a recent survey of hospital administrators. The trend underscores the shift across the healthcare system away from high-cost settings toward lower-cost outpatient utilization.

Healthcare venture capital funding to hit new high in 2018

Venture capital funding continues to pour into healthcare startups, and the pace this year is already expected to top 2017's total figure of $15 billion.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”